By Anthony O. Goriainoff
Shares in NetScientific PLC rose Monday after it said it has successfully completed the evaluation of AstraZeneca PLC's Covid-19 antibody test.
Shares at 0725 GMT were up 13 pence, or 19%, at 82 pence.
The London-listed life sciences, technology, investment and commercialization company said its subsidiary, ProAxsis, completed the test's development and validation with "impressive performance evaluation...